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Follicular T-helper (TFH) cells cooperate with GL7
+CD95+ germinal
center (GC) B cells to induce antibody maturation. Herein, we iden-
tify the transcription factor IRF4 as a T-cell intrinsic precondition
for TFH cell differentiation and GC formation. After immunization
with protein or infection with the protozoon Leishmania major,
draining lymph nodes (LNs) of IFN-regulatory factor-4 (Irf4−/−) mice
lacked GCs and GC B cells despite developing normal initial hyper-
plasia. GCs were also absent in Peyer’s patches of naive Irf4−/−
mice. Accordingly, CD4+ T cells within the LNs and Peyer’s patches
failed to express the TFH key transcription factor B-cell lymphoma-
6 and other TFH-related molecules. During chronic leishmaniasis,
the draining Irf4−/− LNs disappeared because of massive cell death.
Adoptive transfer of WT CD4+ T cells or few L. major primed WT
TFH cells reconstituted GC formation, GC B-cell differentiation, and
LN cell survival. In support of a T-cell intrinsic IRF4 activity, Irf4−/−
TFH cell differentiation was not rescued by close neighborhood to
transferred WT TFH cells. Together with its known B lineage-spe-
cific roles during plasma cell maturation and class switch, our
study places IRF4 in the center of antibody production toward T-
cell–dependent antigens.
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Apart from Th1 and Th2, the family of Th subsets now includesTh17 and Th9 (1). In addition, follicular T-helper (TFH) cells
are defined based on their location within germinal center cells
(GCs) of lymphoid organs (2, 3). Here, these cells produce cyto-
kines that normally define other subsets, such as the Th2 product
IL-4 (4, 5) or the Th17 product IL-21 (6), which is involved in GC
B-cell generation (7–10). TFH cell propagation is supported by the
transcription factor B-cell lymphoma (BCL)-6 and suppressed by
Blimp1 (11–13). Further markers used to define TFH cells include
inducible costimulator (ICOS), programmed death-1 (PD-1), and
CXC-chemokine receptor 5 (CXCR5), which mediate their mi-
gration into GCs (2, 14–16).
The IFN-regulatory factor (IRF) family of transcription fac-
tors includes nine members in mammals that bind to related
target-gene sequences (17). We and others have described im-
portant roles of IRFs during Th cell differentiation. In particular,
IRF1 is decisive for Th1 cell generation because it is ubiquitously
expressed and redundantly addresses many genes with in-
dependent Th1-supporting function (17–19). In contrast, IRF4
controls Th2 and Th17 cell differentiation (20–23), with ensuing
total resistance of Irf4−/− mice in a Th17-dependent mouse
model of multiple sclerosis (24). In addition, regulatory T-cell
(Treg)-specific IRF4 deficiency or lack of IRF4 binding protein
lead to a generalized autoimmune syndrome (25, 26). Finally, we
reported on the role of IRF4 during Th9 differentiation (27).
Remarkably, IRF4 is also a B-cell intrinsic prerequisite for class
switch and plasma cell maturation (28, 29).
Given these pleiotropic activities of IRF4 on B and T cells, we
wondered whether IRF4 also contributes to the interaction of
TFH and GC B cells. Herein, we use chronic leishmaniasis, a
model infection with prominent T- and B-cell interactions (30) to
prove a decisive T-cell intrinsic role of IRF4 for murine TFH cell
development.
Results
Irf4−/−Mice Fail to Generate GCs. To study the development of TFH
cells in vivo, we infected Irf4−/− mice and Irf4-competent control
mice with Leishmania major (30). Two weeks later, draining
popliteal lymph nodes (LNs) were analyzed (Figs. 1 and 2). By
immunohistology, prominent GC formation was observed in WT
and Irf4+/− LNs, including presence of GL7+ GC cells (Fig 1A).
In contrast, GCs were totally absent in Irf4−/− LNs and few GL7+
cells were dispersed throughout the LN. However, Irf4−/− LNs
did contain normal B and CD4 T-cell areas (Fig. 1A, Bottom
Right). We confirmed the lack of GCs in Irf4−/− mice that were
immunized with the myelin oligodendrocyte glycoprotein
(MOG) peptide instead of L. major infection (Fig. S1) and in
Peyer’s patches (PP) from naive mice (Fig. 3A).
A strong reduction in GC B cells coexpressing the markers
GL7 and CD95 (31, 32) was verified by flow-cytometry of single
LN cell suspensions from L. major infected Irf4−/− mice (Fig. 1B,
note the compiled data of three different experiments). Again,
the finding was reproduced in PP from naive mice (Fig. 3B). In
control FACS-stainings, GL7 was only weakly expressed on WT
and Irf4−/− CD4+ cells. Thus, Irf4−/− mice form the architecture
of normal LNs, but lack GC formation. Furthermore, the ICOS
ligand (ICOSL) molecule was strongly up-regulated on Irf4−/− B
compared with WT B cells (Fig. 1C), possibly because of a
feedback-loop between ICOSL and its partner ICOS (33)
expressed on TFH cells. Together with missing GC formation,
these findings suggest a defect in TFH cells within Irf4
−/− mice.
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Irf4−/− Mice Fail to Generate TFH Cells. To directly test this theory,
LN cells of L. major infected mice were analyzed for expression of
TFH marker molecules. In Irf4
+/−mice, TFH cells expressing BCL-
6, IL-21, and PD-1 were present and coexpressed ICOS at high
(ICOShi) or intermediate (ICOSint) levels. Importantly, Irf4−/−
CD4+ cells totally lacked ICOShi cells, although ICOSint cells
were present at even enhanced frequency (Fig. 2A). Both findings
were confirmed in PP of naive mice (Fig. 3C). As for PD-1, its
expression was comparable in CD4+ cells of infected Irf4−/− and
Irf4+/− mice (Fig. 2A), but was also reduced in Irf4−/− CD4+ cells
of naive PP (Fig. 3C). Furthermore, amounts of BCL-6 protein,
a central molecule for TFH cell function (11–13), were consider-
ably lower in Irf4−/− than in Irf4+/− CD4+ cells (Fig. 2B).
An even stronger defect was noted with respect to IL-21
production (Fig. 2C): after short-term restimulation, IL-21 pro-
tein was synthesized by many of the ICOShi and ICOSint Irf4+/−
control cells (thus further characterizing them as the source of
TFH cells), but not by Irf4
−/− CD4+ cells (Fig. 2C, Left). To
measure expression of Il-21 at the mRNA level, we performed
quantitative PCR (qPCR) directly ex vivo (Fig. 2C, Right) after
sorting ICOShi (only control mice), ICOSint, and ICOSlo cell
populations (Fig. 2A), Again, most Il-21 mRNA was detected in
ICOShi Irf4+/− control cells, but the lower levels in ICOSint cells
were further reduced in their Irf4−/− counterparts. These data
demonstrate a striking defect of Irf4−/− CD4+ cells to express
TFH cell markers.
Analysis of CXCR5 Expression. Expression of the CXCR5 molecule
permits TFH cell migration into GCs (16), but is found at even
higher levels in B cells (15). Recently T–B conjugates have been
described in FACS analyses of LN cell preparations (5). These
conjugates might contain TFH cells tightly interacting with B cells
and complicate testing of CXCR5 expression on T cells. Indeed,
we identified CD4+ events with considerable CXCR5 costaining
(Fig. S2A) as aggregates of CD4+ T and B220+ B cells (Fig.
S2B). In contrast, CXCR5-staining was weaker on single CD4+
T cells, despite nice staining of single B cells within the same
sample (Fig. S2B). Mechanical dissociation and reanalysis con-
firmed lower CXCR5 staining on T cells. Thus, outgating of B–T
conjugates did not remove any TFH cells with particularly strong
CXCR5 staining, and was routinely used during data acquisition
(with the exception of Figs. S2 and S3). We detected B–T con-
jugates not only in the Leishmania model, but also in PP of naive
mice (Figs. S2 and S3) or after MOG immunization. Although
CXCR5 clearly remains a marker of TFH cells, these T–B con-
jugates suggest critical care during its staining on T cells.
When we now compared CXCR5 expression on Irf4−/− and
WT cells, we found that CXCR5 staining was totally absent in
Irf4−/− CD4+ cells (Fig. 2D), confirming their lack of TFH cells.
Importantly, this conclusion required exclusion of B–T con-
jugates from the analysis (Fig. S3, gate B), because gating on all
viable CD4+ events revealed CD4+CXCR5+ events (Fig. S3A)
as a result of aggregating CXCR5-expressing Irf4−/− B cells (Fig.
S3B, gate A). Mechanical disruption of the conjugates and
reanalysis confirmed these conclusions (Fig. S3C) and excluded
removal of CXCR5+ Irf4−/− TFH cells. As anticipated, we found
a positive correlation for expression of CXCR5 and BCL-6 in
Irf4+/−mice (Fig. 2E). Similar data were gained from PP of Irf4−/−
mice (Fig. 3C, and Fig. S3 D and E). Taken together, these data
strongly suggest that Irf4−/− T cells do not differentiate into TFH
cells in vivo, but CXCR5 deficiency may explain lack of GC
formation in Irf4−/− mice because of altered T-cell migration.
Fig. 1. Lack of GC formation in Irf4−/−mice. Mice of the indicated genotypes
were infected with L. major. Two weeks later, popliteal LNs were prepared.
(A) Tissue sections were stained for CD4 (red), GL7 (green, Left), or B220
(green, Right), and analyzed by fluorescence-microscopy (20×magnification).
(Scale bars, 50 μm.) (B and C) LN cell suspensions were stained for the
indicated surface molecules and analyzed by flow cytometry. Numbers in-
dicate percentages of positive cells in the respective circles or rectangles.
Panels are from one representative mouse per group. Three different
experiments, each with two or three mice per group. (B) B220+ B-cell gate.
Percentages (mean ± SD) of GL7+CD95+ B cells compiled from all mice tested.
Fig. 2. Lack of TFH cells in L. major infected Irf4
−/− mice. Irf4−/−, WT mice,
and Irf4+/− mice (three per group) were infected with L. major and their
popliteal LN cells analyzed 2 wk later for expression of extracellular ICOS,
CXCR5, and PD-1 (A) and intracellular BCL-6 (B) and IL-21 (C). (A; B; C, Right;
D; and E) Direct ex vivo analysis. (C) Analysis after restimulation for 4 h with
PMA and ionomycin (Left). (Right) CD4+ cells from pooled LN cells of all mice
per group sorted according to ICOS expression (see A), and analyzed for
IL-21 compared with HPRT (hypoxanthine-guanine phosphoribosyl trans-
ferase) expression by RT qPCR. Bars denote the SD of duplicate qPCR
determinations of each sample. The asterisk signifies that this value was set
to one. n.t., not tested. (D and E) Single CD4+ cells were gated similar to gate
B of Fig. S2B. Numbers in A–E indicate percentages of cells in the respective
rectangles. Data are from one representative mouse per group. Three
experiments with similar outcomes.









To rule out a defect of Irf4−/− T cells in their receptor-trig-
gered antigenic response as a trivial reason for TFH cell de-
ficiency, we restimulated LN cells of infected mice in vitro. In
response to Leishmania antigens, Irf4−/− and Irf4+/− control
CD4+ cells secreted the precursor T-cell product IL-2 into their
supernatants at the same order of magnitude (Fig. S4A). Simi-
larly, the frequency of intracellularly stained IL-2–producing
CD4+ cells was similar between the two genotypes (Fig S4B).
Lack of Irf4−/− TFH Cells Is Not Caused by a Cell Viability Problem.
Previously, we reported on apoptotic death of Irf4−/− draining
LN cells after about 6 wk of leishmaniasis (34). We therefore
aimed to exclude that a cell viability problem hindered GC for-
mation earlier after infection. In naive young Irf4−/− and Irf4+/−
mice, the size of popliteal LNs was comparable (about 1 × 106
cells). Furthermore, the increase in LN size and histological
appearance 2 wk after infection were similar (Fig. 4 A and B),
but Irf4−/− and Irf4+/− CD4+ LN T cells were comparably able to
secrete IL-2 (Fig. S4) and to proliferate in response to phorbol
12-myristate 13-acetate (PMA) and ionomycin (Fig. 4C). These
data confirm functional integrity of Irf4−/− LN CD4+ T cells at
the time point when the lack of GC formation was noted. In
contrast, Irf4−/− LNs had almost totally disappeared 6 wk after
infection (Fig. 4A), and severe damage in LN cell morphology
was already visible 4 wk after infection (Fig. 4B). Cell death did
not occur in other LNs of infected Irf4−/− mice. The divergence
in LN cell viability of WT and Irf4−/− mice 6 but not 2 wk after
infection is underscored by the compiled statistical significance
of all mice tested (Fig. 4A). In conclusion, lack of Irf4−/− GC
formation cannot be explained by disturbed cell viability.
Rescue of GC Formation by WT CD4+ T Cells. Although a primary
Irf4−/− TFH cell defect was likely, a B-cell defect with altered T–B
interactions and secondary TFH cell deficiency remained possi-
ble. To directly prove a T-cell intrinsic TFH promoting IRF4
activity, Irf4−/− mice were reconstituted intraperitonially with
purified CD45 (Ly5.1+) congenic CD4+ cells from naive mice at
the start of infection. Two weeks later—that is, at the maximum
of GC formation in WT mice—transferred WT CD4+ T cells
had perfectly rescued the appearance of GCs and GL7+ Irf4−/− B
cells (Fig. 5A). Furthermore, the WT cells tended to accumulate
close to the GC areas, but endogenous CD4+ T cells mostly
remained outside of them. By flow cytometry, WT CD4+ T-cell
transfer totally rescued the generation of Irf4−/− GL7+CD95+
GC B cells (Fig. 5B) and the compensatory up-regulation of
ICOSL on Irf4−/− B cells was almost reverted (Fig. 5C). Because
WT CD4+ cells can induce GC formation and GC B-cell dif-
ferentiation in Irf4−/− mice, their TFH defect is caused by an
intrinsic T- but not B-cell defect. Accordingly, B-cell–specific
deficiency in IRF4 leads to disturbed plasma cell differentiation,
but no change in GC formation (28). However, this plasma cell
defect precludes demonstration of effects of the transferred WT
CD4+ T cells on antibody formation in our mice.
Rescue of LN Cell Survival by WT CD4+ T Cells. Like GC formation,
LN cell survival 6 wk after infection was rescued to a great
extent by transferred CD4+ cells and normal histological mor-
phology was regained (Fig. 6 A and B). Most of the surviving LN
cells did not express the Ly5.1 marker of the transferred WT
cells (Fig. 6C) and Ly5.1-expressing cells were all CD4+. Thus,
LN cell viability was not secondary to outgrowth of WT CD4+
cells. Instead, WT CD4+ cells caused improved survival of en-
dogenous Irf4−/− B and T cells. Of note, WT CD4+ T cells were
perfectly able to become ICOShi cells within Irf4−/− LNs (Fig.
6C). Thus, the defect in Irf4−/− TFH cells is not caused by
deficiencies of accessory cells (e.g., in antigen presentation or
production of necessary cofactors). Furthermore, even the side-
by-side presence of WT TFH cells did not catalyze ICOS
hi ex-
pression, and thus TFH cell differentiation in endogenous
Ly5.1− Irf4−/− CD4+ T cells (Fig. 6C).
Unlike T cells, transferred WT B cells neither protected LNs
from cell death nor modified the effect of WT CD4+ cells (Fig.
6A). As a positive control for their functionality, we took ad-
vantage of the unrelated Irf4−/− B-cell defect (28, 35), leading to
drastically reduced serum IgM levels. Analysis of mouse sera
after B-cell transfer revealed that the transferred WT B cells
raised IgM in Irf4−/− mice almost to WT amounts (Fig. S5A).
Rescue of LN survival mirrored susceptibility toward L. major:
transferred WT CD4+, but not B cells, led to a healing pheno-
type, as measured by lesion size and parasite burden and com-
pared with control Irf4+/− mice (Fig. S5 B and C). However, a
high parasite load is probably not the main reason for ensuing
cell death in Irf4−/− LN cells, because susceptible BALB/c or
IRF1-deficient mice contain even more Leishmania (18), but
keep the original size of the LN and develop a cheesy necrosis
inside of it.
To formally link TFH cells and protection from cell death, we
transferred as few as 2 × 105 FACS-sorted (Fig. S6) WT TFH cells
from LNs and spleens of L. major infected Ly5.1+ WT mice. For
comparison, ICOS−CXCR5− CD4+ T cells from the same organs
were transferred into different Irf4−/−mice. All mice were infected
and the draining LNs analyzed 6 wk later. Transfer of TFH cells,
but not of ICOS−CXCR5− CD4+ T cells rescued endogenous LN
cell viability, as seen from cell numbers and normal proliferative
behavior (Fig. 6 D and E). Transferred TFH cells also rescued
Fig. 3. Lack of TFH cell differentiation in PP of naive Irf4
−/−mice. (A–C) PP of
naive mice were analyzed as described for Figs. 1 and 2.
Fig. 4. Disappearance of lesion-draining LNs in L. major infected Irf4−/−
mice. Mice of the indicated genotypes were infected with L. major. At the
indicated time points, popliteal LNs were prepared and (A) cell numbers in
single-cell suspensions counted (mean ± SD) or (B) tissue sections processed
for HE staining and microscopy (40× magnification). (Scale bars, 10 μm.) (C)
To control for proliferative capacity 2 wk after infection, cells were labeled
with 5-(and 6)-carboxyfluorescein diacetate succinimidyl ester (CFSE), stim-
ulated for 72 h with PMA/ionomycin, and stained for CD4. Data are repre-
sentative of five (A) or three (B and C) different experiments, each with
three mice per group and (B and C) show the results of one representative
mouse per group.
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a resistant phenotype during leishmaniasis (Fig. S5D), and
ICOS−CXCR5− CD4+ T cells did not. Taken together, these data
suggest a link between the TFH cell defect and cell death in the
draining Irf4−/− LNs during chronic leishmaniasis.
Role of IL-21. Next, we considered lack of a particular TFH cell
product as primary cause of LN cell death and missing Irf4−/−
GC formation. An important candidate was IL-21, which is in-
duced within TFH cells via the ICOS–c-Maf axis (9, 36) and is
required for GC B-cell differentiation (7–10). We considered IL-
21 as well, because expression of ICOS and IL-21 by Irf4−/− cells
is disturbed (Fig. 2 and ref. 21), and because IRF4 binds the
ICOS promoter (25) and mediates cell responses to IL-21 to-
gether with STAT3 (37). To test for a role of IL-21, we compared
the effects of adoptively transferred purified Il21−/− and WT
CD4+ T cells on GC formation and LN cell survival in Irf4−/−
mice 2 wk after infection (Fig. 7).
Although transferred WT cells again perfectly rescued the
appearance of GCs and GL7+ cells (Fig. 7A), only few GL7+
cells were detectable after transfer of Il-21−/− CD4+ cells and
were spread throughout the LN as in control Irf4−/− mice. Fur-
thermore, transferred WT but not Il-21−/− CD4+ cells rescued
the frequency of GL7/CD95 coexpressing GC B cells (Fig. 7B),
in comparison with Irf4−/− mice without cell transfer.
To analyze whether IL-21 was also involved in the rescue of
LN cell survival by WT cells (Fig. 6), part of the mice was ana-
lyzed 6 instead of 2 wk after infection. Transfer of Il-21−/− CD4+
cells created an intermediate phenotype compared with Irf4−/−
mice receiving either no or WT CD4+ T cells (Fig. 7C). Accu-
mulation of all data from the different experiments revealed less
potent effects of Il-21−/− than of WT CD4+ cells with clear
statistical difference. However, even if their effects on Irf4−/− LN
cell survival were weaker, they still were demonstrable with high
significance compared with Irf4−/− mice without cell transfer.
Discussion
In the past, IRF4 has been characterized as an important tran-
scription factor for differentiation of Th2, Th9, and Th17 cells.
In addition, aspects of Treg cell function entirely depend on
IRF4 (20–23, 25–27). In the B-cell lineage, IRF4 is important for
plasma cell differentiation and isotype switching (28, 29). Our
results link these previous findings in B and T cells and show an
additional important role of IRF4 for development of TFH cells,
which are mainly responsible for the intricate organization of T–
B interactions and antibody maturation in vivo.
For our analysis, we used infection of mice with L. major, a
model characterized by strong B- and T-cell interactions and LN
hyperplasia (30). When analyzing LNs of WT and Irf4−/− mice at
the height of GC formation in WT mice, a striking defect of
Irf4−/− mice became apparent: despite normal structure of B-
and T-cell areas, their LNs totally lacked GC formation and
differentiation of GC B cells. These findings were confirmed in
PPs of naive mice and after immunization with a peptide instead
of L. major infection. In parallel, LN CD4+ T cells expressed
strongly reduced amounts of the TFH cell-related (2, 11–13, 15,
16) molecules ICOS, IL-21, and BCL-6.
A remarkable result was obtained with respect to the TFH
marker CXCR5 in that LN cell suspensions contained conjugates
of adherent B–T cells, which conferred the risk for misinter-
preting FACS data on CXCR5-expression in CD4+ T cells,
Fig. 5. Rescue of GC formation by WT CD4+ T cells. Irf4−/− mice (A–C) or Irf4+/− mice (B and C) were infected with L. major. Where indicated, Irf4−/− mice
received 8 × 106 Ly5.1 congenic WT CD4+ cells by intraperitoneal adoptive transfer on the day of infection. Two weeks later, popliteal LNs were prepared. (A)
Tissue sections were stained with antibodies to CD4 (blue), Ly5.1 (red), and GL7 (green) followed by fluorescence-microscopy (20×magnification). (Scale bars,
50 μm.) (B and C) Cells in suspension were stained for B220, GL7, ICOSL, and CD95 and analyzed (B220+ gate) by flow cytometry. Numbers refer to percentages
in the quadrant below the number (C) or within the indicated gate (B). SSC, side scatter. Data are from one representative mouse per group. Three (A) or two
(B and C) different experiments, each with three mice per group, were performed with similar outcome.









because of stronger CXCR5 expression on B cells. Similar B–T
conjugates have recently been described and characterized for
their B-cell part (5). The lower amounts of CXCR5 on single T
cells correlated with high expression of ICOS and IL-21, in-
dicating that CXCR5 can still be used to characterize TFH cells.
These findings were again confirmed in LNs of mice immunized
with a peptide or in PPs from naive mice.
Integration of this information in the analysis of Irf4−/− TFH
cell development revealed that Irf4−/− LN CD4+ cells were
completely CXCR5−. Importantly, this defect was only notable
when the B–T conjugates were either out-gated or mechanically
separated, because CXCR5 expression on Irf4−/− B cells was as
high as in WT mice. Lack of CXCR5 on Irf4−/− CD4+ but not B
cells suggests a T-cell intrinsic differentiation defect that cannot
solely be caused by binding of IRF4 to the cxcr5 gene promoter.
With respect to ICOS, its promoter has previously been linked to
IRF4 (25). However, ICOS expression is not totally IRF4-de-
pendent, because frequencies of Irf4−/− cells with intermediate
ICOS expression were even increased (Figs. 2 and 3), perhaps in
a feedback-loop triggered by deficient terminal TFH cell differ-
entiation. Lower ICOS expression may be one reason why Irf4−/−
T cells produced almost no IL-21, because Il-21 transcription is
induced by an axis via ICOS and c-Maf (36). However, impaired
IL-21 production may also mirror an intrinsic deficiency of Irf4−/−
T cells, given that naive Irf4−/− CD4+ T cells stimulated in vitro
under Th17-inducing conditions also produced less IL-21 (21). In
contrast to ICOS, the TFH cell marker PD-1 was normally
expressed in T cells of L. major infected Irf4−/− mice. Therefore,
missing T-cell stimulation is unlikely to explain absent Irf4−/−
TFH cell development, a conclusion supported by normal IL-2
production in response to Leishmania antigens.
Importantly, missing Irf4−/− TFH cells and GCs correlated with
eventual total LN cell death after initial LN hyperplasia. We
have previously described enhanced in vitro sensitivity of Irf4−/−
CD4+ cells to activation-induced cell death (34). Herein, we
observed that death of Irf4−/− LN cells could be avoided by
presence of WT CD4+ but not B cells. Only few CD4+ WT cells
were required for protection, based on their low frequency
within the surviving LN cells. LN cell survival was also saved by
very few Leishmania primed WT TFH cells, thus linking TFH cells
and protection from cell death. LN cell survival correlated with
resistance to the parasite. Nevertheless, it is difficult to attribute
this feature solely to the presence of TFH cells, because Irf4
−/−
mice are also devoid of Th9 or Th17 cells (20, 26, 27). A direct
causal link of parasite burden and LN cell survival is not likely,
given that draining LNs of mice from other highly susceptible
strains behave totally differently.
Of note, adoptive transfer of WT CD4+ cells rescued not only
LN cell survival, but also appearance of GCs and GC B cells with
normalized expression of ICOSL in accordance with the feed-
back-loop between ICOS and ICOSL (33). These findings un-
derline that the Irf4−/− TFH cell defect is T-cell intrinsic and
support a report on normal GC formation in mice with a B-cell–
specific defect of IRF4 (28). Transfer of Il-21−/− CD4+ T cells
proved a central role for IL-21 during the rescue of GC forma-
tion. In contrast, IL-21 was necessary but not sufficient for
protection from LN cell death, because Il-21−/− CD4+ T cells
supported cell survival only partially. LN cell survival during
a chronic immune response is of central importance and may be
regulated by independent effector molecules, such as IL-4, which
is produced locally by TFH cells (4, 5) and which (like IL-21)
cannot be produced by Irf4−/− Th cells (22, 23).
As for the mechanism how IRF4 affects TFH cell differentia-
tion, we consider an important role to their key transcription
factor BCL-6 (11–13), because its amounts are strongly reduced
in Irf4−/− CD4+ T cells. Apparently, this BCL-6–enhancing
function of IRF4 is cell-type–specific, because IRF4 suppresses
BCL-6 transcription in B cells (38). In addition, IRF4 physically
binds to BCL-6 (39) and lack of this interaction may explain why
Irf4−/− Th cells are totally unable to differentiate into TFH cells,
Fig. 6. Rescue of LN cell survival by WT CD4+ cells. (A–C) Where indicated,
Irf4−/− mice received 8 × 106 Ly5.1 congenic WT B or CD4+ cells or both by
intraperitoneal transfer, were infected, and analyzed 6 wk later in com-
parison with infected WT or Irf4+/− mice. (A) Popliteal LN cell numbers. (B)
H&E staining (40×magnification) (Scale bars, 10 μm.) (C, Upper) total life cell
gate. Numbers refer to the percentage of CD4+Ly5.1− or CD4+Ly5.1+ among
total cells. (Lower) Relative cell percentages among CD4+Ly5.1+ cells (Upper
numbers) or CD4+Ly5.1− cells (Lower) within the respective rectangles. (D
and E) TFH cells (CD4
+ICOShiCXCR5+) or control CD4+/ICOS−/CXCR5− cells
sorted (Fig. S6) from 2 wk-infected Ly5.1+ WT mice were transferred in-
traperitoneally (2 × 105 per mouse) into Irf4−/− mice which, together with
control mice, were infected with L. major. After 6 wk, cell numbers of the
draining LNs were counted (D) and the proliferative capacity of the cells
determined by CFSE dilution (E). Data are representative of three (A–C) or
two (D and E) different experiments, each with three (A–C) or two (D and E)
mice per group. (D) Accumulated data ± SD of all mice per group in the two
experiments or data from one representative mouse (E).
Fig. 7. Role of IL-21. Irf4−/− mice were infected with L. major. Where indi-
cated, they also received 8 × 106 purified Il21−/− or WT CD4+ cells by intra-
peritoneal adoptive transfer. Two weeks (A and B) or 6 wk (C) after infection,
draining LNs were prepared (B and C) as cell suspensions. (A) Tissue sections
stained with antibodies to CD4 (red) and GL7 (green) and analyzed by fluo-
rescence-microscopy (20× magnification). (Scale bars, 50 μm.) (B) FACS anal-
ysis of gated B220+ B cells stained for GL7 and CD95. Numbers indicate
frequencies of B cells coexpressing GL7 and CD95. (C) Cell numbers within the
draining LNs of individual mice with or without transfer of the indicated cells.
Data are from onemouse representative for all experiments (A and B) or were
compiled from the results of three individual experiments (C).
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although they still express some BCL-6. Possibly, the TFH in-
ducing capacity of BCL-6 requires its interaction with IRF4.
In conclusion, we demonstrate a decisive role of IRF4 for
development of TFH cells and, as a consequence, formation of
GCs, differentiation of GC B cells, and survival of LN cells
during an immune response. Together with the earlier findings
that IRF4 also targets class-switching and terminal plasma cell
differentiation, our study places IRF4 in the center of B–T co-
operation during the formation of an adaptive immune response.
Materials and Methods
Mice and L. major Infection or Immunization. WT C57BL/6 mice, purchased
from Charles River, CD45.1 congenic, Il-21−/− (from National Institutes of
Health Mutant Mouse Regional Resource Centers), and Irf4+/− and Irf4−/−
mice (bred in our own animal facilities) were used at 6–10 wk of age. In-
fection with promastigotes of the L. major strain MHOM/IL/81/FEBNI into the
footpad, determination of lesion development or parasite burden, and
leishmania-specific in vitro cell restimulation were performed as previously
described (18, 34). Popliteal LNs or spleens were removed at the indicated
timepoints for histology, qPCR, and FACS analysis, as detailed in SI Materials
and Methods.
Total IgM levels were measured in a sandwich ELISA by coating with goat
anti-mouse IgM followed by application of mouse sera and detection with
AP-conjugated goat anti-mouse IgM (both reagents from Chemicon/Milli-
pore). Immunization with MOG peptide and adjuvant was performed as
previously described (20). All animal experiments were approved by
“Regierungspräsidium Gießen” [permission number: V54-19c20-15(1) MR 20/
6 Nr47/2009], the local institutional committee.
Statistics. For statistical analysis, we used an unpaired t test with Welch’s
correction.
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